Joscelyn Cekola "Josie" Boucher
- Executive Partner
My admin
- Cathy Greenlee
industries
practices
- Advises clients on transaction structure, strategy and general legal matters.
- Represented a cancer therapeutic development company in a various series of convertible note and preferred stock financings, culminating in a $60M Series D financing round, and ultimate initial public offering.
- Represented a medical device company in an $8 million Series A preferred stock financing.
- Represented a cancer diagnostic company in a $2 million convertible debt offering and $5 million Series A financing.
- Represented a dental medical device company in a $4 million Series A preferred stock financing.
- Represented a biomedical company in the conversion of the company from a limited liability company to a corporation and subsequent
- Advises clients on transaction structure, strategy and general legal matters.
- Represented a cancer therapeutic development company in a various series of convertible note and preferred stock financings, culminating in a $60M Series D financing round, and ultimate initial public offering.
- Represented a medical device company in an $8 million Series A preferred stock financing.
- Represented a cancer diagnostic company in a $2 million convertible debt offering and $5 million Series A financing.
- Represented a dental medical device company in a $4 million Series A preferred stock financing.
- Represented a biomedical company in the conversion of the company from a limited liability company to a corporation and subsequent $5 million Series A preferred stock financing.
- Represented an agricultural biotechnology company in various series of convertible note and preferred stock financings, including a $18 million Series D preferred stock financing.
- Represented a biotech company in a $1 million common stock financing.
- Represented a drug development company in its conversion from a corporation into a limited liability company and $32.5 million Series D preferred equity financing.
- Represented a drug development company in the spin out of an asset and subsequent $20 million Series A-1 preferred stock financing and $40 million Series A-2 preferred stock financing.
- Represented a clinical stage biopharmaceutical company in its initial public offering.
- Represented a $20 million venture capital fund in fund formation and investment matters.
- Represented a private equity fund with over $1 billion in capital under management in various growth capital investments in emerging growth companies.
- Represented a family office in preferred equity investments in innovative food companies.
- Negotiated a License Agreement on behalf of a cancer therapeutic drug development company with a publicly traded biotechnology company.
- Negotiated a cross-license agreement on behalf of a cardiac monitoring device company with a Fortune 500 medical device company.
- Negotiated a license agreement on behalf of a biotechnology company with an Indian manufacturer of xylitol.
- Negotiated distribution and manufacturing agreements on behalf of a publicly traded cardiac medical device company.
- Negotiated a collaboration agreement on behalf of an agricultural biotechnology company with multinational publicly traded agrochemical and agricultural biotechnology company.
- Negotiated a toll manufacturing agreement on behalf of an agricultural biotechnology company with an Italian manufacturer.
- Represented a media company in its acquisitions of an Indian-based internet company and a venture-backed internet company for automotive enthusiasts.
- Represented a media company in acquisition of a specialty newspaper line and magazine.
- Represented an aftermarket automotive parts supplier in numerous acquisitions and divestures.
- Represented and advised a Fortune 500 publicly traded company in connection with internal international restructuring transactions.
- “Show Me the Money! Raising Funds for Startups,” Innovation Lunch-and-Learn Series, Kalamazoo, Michigan, April 24, 2019
- “Financing Your Start-Up: Venture Capital Basics,” Innovation Lunch-and-Learn Series, Kalamazoo, Michigan, April 19, 2018
- “Show Me the Money! Raising Funds for Startups,” Innovation Lunch-and-Learn Series, Kalamazoo, Michigan, April 24, 2019
- “Financing Your Start-Up: Venture Capital Basics,” Innovation Lunch-and-Learn Series, Kalamazoo, Michigan, April 19, 2018
